title: Prognostic value of different amounts of cancer stem cells in different molecular subtypes of breast cancer.
abstract: OBJECTIVE
  To investigate the differences in the amount of cancer stem cells in different breast cancer subtypes.
  
  
  METHODS
  THE SPECIMENS OF BREAST CANCER TISSUES WERE DIVIDED INTO FIVE GROUPS: group A (luminal A type), B (luminal B type), C (HER-2 + type), D (basal-like type) and E (normal-like type) according to their molecular subtypes. The cancer stem cell spheres in each group were measured through colony formation method, and then the relations of the amount of cancer stem cells with the subtypes of breast cancer were analyzed.
  
  
  RESULTS
  The numbers of cancer stem cell spheres in group A and B were (1.1±0.2)/1,000 cells and (1.3±0.1)/1,000 cells, respectively, and this had no significant difference (P>0.05). The number of cancer stem cell spheres in group C was (8.6±1.0)/1,000 cells, which was significantly higher than that in group A and B (both P<0.05). The numbers of cancer stem cell spheres in group D and E were (22.4±1.2)/1,000 cells and (17.7±2.0)/1,000 cells, respectively, and this was statistically similar (P>0.05) but either was significantly higher than that in the other three groups (all P<0.05).
  
  
  CONCLUSIONS
  Breast cancer tissues of different molecular subtypes contain varying amounts of cancer stem cells, and this may have certain significance for predicting the prognosis of breast cancer.
authors.affiliation: Department of Oncology Surgery, Fujian Provincial Hospital, Fuzhou 350001, China.
authors.forename: Guohua
authors.initials: G
authors.lastname: Yang
authors.affiliation: Department of Oncology Surgery, Fujian Provincial Hospital, Fuzhou 350001, China.
authors.forename: Fangqing
authors.initials: F
authors.lastname: Xue
authors.affiliation: Department of Oncology Surgery, Fujian Provincial Hospital, Fuzhou 350001, China.
authors.forename: Xiaogeng
authors.initials: X
authors.lastname: Chen
keywords: Breast neoplasms; molecular subtype; neoplastic stem cells; prognosis
references.citation: Cancer Immunol Immunother. 2012 Aug;61(8):1255-68
references.pmid: 22270714
references.citation: Breast Cancer Res. 2008;10(3):R53
references.pmid: 18559090
references.citation: Histol Histopathol. 2010 Mar;25(3):371-85
references.pmid: 20054808
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Cell Stem Cell. 2007 Nov;1(5):555-67
references.pmid: 18371393
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
references.pmid: 17671126
references.citation: Lab Invest. 2008 May;88(5):459-63
references.pmid: 18379567
references.citation: J Pathol. 2008 Jan;214(1):25-37
references.pmid: 17973239
references.citation: Breast Cancer Res. 2006;8(5):R58
references.pmid: 17054791
references.citation: Breast Cancer Res. 2008;10(1):R10
references.pmid: 18241344
references.citation: J Mammary Gland Biol Neoplasia. 2009 Mar;14(1):79-82
references.pmid: 19259795
references.citation: Hum Pathol. 2008 Jul;39(7):1096-102
references.pmid: 18495204
references.citation: JAMA. 2006 Jun 7;295(21):2492-502
references.pmid: 16757721
references.citation: Int J Biol Sci. 2008 May 04;4(3):133-42
references.pmid: 18461147
references.citation: J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85
references.pmid: 17179479
references.citation: J Natl Cancer Inst. 2008 May 7;100(9):672-9
references.pmid: 18445819
references.citation: J Cell Mol Med. 2009 Feb;13(2):309-319
references.pmid: 18410528
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Curr Opin Genet Dev. 2006 Feb;16(1):60-4
references.pmid: 16377171
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5
references.pmid: 18230721
references.citation: Womens Health (Lond). 2011 Mar;7(2):181-202
references.pmid: 21410345
references.citation: Cell Cycle. 2009 Oct 15;8(20):3297-302
references.pmid: 19806016
references.citation: Oncogene. 2008 Oct 16;27(47):6120-30
references.pmid: 18591932